title: Eph-ephrin bidirectional signaling comes into the context of lymphocyte transendothelial migration.
abstract: A better knowledge of the molecular mechanisms that govern leukocyte trafficking is of major relevance for the clinics. Both normal and pathologic extravasation of lymphocytes are a fine-tuned spatio-temporal event of migratory path-finding likely regulated by molecular guidance cues underlying cell movements in other systems. We have recently reported that members of the Eph family of receptor tyrosine kinases, namely EphA2 and one of its ligands, ephrin-A4 (EFNA4) can mediate in the traffic of chronic lymphocytic leukemia (CLL) cells and presumably of normal B cells between the blood and the tissues. The importance of EphA2-EFNA4 interactions at the endothelium-lymphocyte interface during TEM could rely on their attractive/repulsive properties. In the present work, we expand on those results by including additional insights and new suggestions for future studies that discuss the relevance of these molecules in overall cell adhesion dynamic events.
authors.affiliation: Microscopy and Cytometry Research Centre, Faculty of Biology, Complutense University of Madrid, Madrid, Spain.
authors.forename: Eva M
authors.initials: EM
authors.lastname: Trinidad
authors.forename: Agustín G
authors.initials: AG
authors.lastname: Zapata
authors.forename: Luis M
authors.initials: LM
authors.lastname: Alonso-Colmenar
mesh_terms: D000818:Animals; D036385:Ephrin-A4 / Q000378:metabolism; D036342:Ephrins / Q000378:metabolism*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000201:enzymology / Q000473:pathology; D008198:Lymph Nodes / Q000201:enzymology / Q000473:pathology; D008214:Lymphocytes / Q000166:cytology* / Q000378:metabolism*; D036104:Receptor, EphA2 / Q000378:metabolism; D036081:Receptors, Eph Family / Q000378:metabolism*; D015398:Signal Transduction; D057705:Transendothelial and Transepithelial Migration
chemical_list: D036385:Ephrin-A4; D036342:Ephrins; D036104:Receptor, EphA2; D036081:Receptors, Eph Family
references.citation: Blood. 2008 May 15;111(10):5173-81
references.pmid: 18326821
references.citation: J Leukoc Biol. 2001 Jun;69(6):860-6
references.pmid: 11404368
references.citation: Cancer Res. 2009 Apr 1;69(7):3121-30
references.pmid: 19293181
references.citation: Mol Immunol. 2008 Mar;45(5):1208-20
references.pmid: 17980912
references.citation: IUBMB Life. 2006 Jul;58(7):389-94
references.pmid: 16801213
references.citation: Trends Immunol. 2007 Aug;28(8):346-52
references.pmid: 17625969
references.citation: Nat Rev Immunol. 2004 Jun;4(6):432-44
references.pmid: 15173832
references.citation: Leuk Lymphoma. 2001 Jun;42(1-2):5-12
references.pmid: 11699221
references.citation: Oncogene. 2000 Dec 7;19(52):6043-52
references.pmid: 11146556
references.citation: Cell. 2005 Apr 8;121(1):127-39
references.pmid: 15820684
references.citation: Am J Anat. 1989 Oct;186(2):115-26
references.pmid: 2816780
references.citation: Curr Opin Cell Biol. 1996 Oct;8(5):714-23
references.pmid: 8939652
references.citation: Trends Cell Biol. 2008 Jun;18(6):298-306
references.pmid: 18468440
references.citation: Cell. 2002 Oct 18;111(2):251-63
references.pmid: 12408869
references.citation: Genes Dev. 2008 Feb 15;22(4):416-29
references.pmid: 18281458
references.citation: J Exp Med. 2000 Aug 21;192(4):495-506
references.pmid: 10952719
references.citation: Nat Rev Immunol. 2005 Oct;5(10):760-71
references.pmid: 16200079
references.citation: Br J Haematol. 1999 Apr;105(1):181-9
references.pmid: 10233382
references.citation: Science. 1997 Mar 14;275(5306):1640-3
references.pmid: 9054357
references.citation: Curr Cancer Drug Targets. 2008 Sep;8(6):473-9
references.pmid: 18781894
references.citation: Nat Cell Biol. 2006 Feb;8(2):156-62
references.pmid: 16429129
references.citation: Curr Top Microbiol Immunol. 2006;308:83-116
references.pmid: 16922087
references.citation: Hematology Am Soc Hematol Educ Program. 2003;:153-75
references.pmid: 14633781
references.citation: Nat Immunol. 2002 Feb;3(2):116-8
references.pmid: 11812986
references.citation: Leuk Lymphoma. 2004 Dec;45(12):2365-72
references.pmid: 15621749
references.citation: Immunity. 2009 Mar 20;30(3):384-96
references.pmid: 19268609
references.citation: Circ Res. 2009 Jul 31;105(3):223-30
references.pmid: 19644057
references.citation: J Clin Invest. 2005 Mar;115(3):755-64
references.pmid: 15711642
references.citation: Eur J Immunol. 1998 Mar;28(3):961-72
references.pmid: 9541591
references.citation: Thromb Res. 2009 Mar;123(5):745-52
references.pmid: 18768213
references.citation: Dev Cell. 2004 Oct;7(4):465-80
references.pmid: 15469835
references.citation: Leuk Lymphoma. 2003 Feb;44(2):223-8
references.pmid: 12688337
references.citation: Nat Immunol. 2005 Dec;6(12):1182-90
references.pmid: 16369557
references.citation: Front Biosci (Landmark Ed). 2009 Jan 01;14:2522-45
references.pmid: 19273217
references.citation: Nat Immunol. 2004 Apr;5(4):351-3
references.pmid: 15052260
references.citation: Sci Signal. 2008 Apr 15;1(15):re2
references.pmid: 18413883
references.citation: Curr Opin Cell Biol. 2008 Apr;20(2):194-200
references.pmid: 18353626
references.citation: Nat Cell Biol. 2006 Feb;8(2):113-23
references.pmid: 16429128
references.citation: Curr Opin Cell Biol. 2007 Oct;19(5):534-42
references.pmid: 17928214
references.citation: Leuk Res. 1983;7(1):1-10
references.pmid: 6834882
references.citation: Nat Rev Mol Cell Biol. 2005 Jun;6(6):462-75
references.pmid: 15928710
references.citation: Cell. 1996 Jul 12;86(1):35-46
references.pmid: 8689685
references.citation: Leuk Res. 2009 Mar;33(3):395-406
references.pmid: 18819711
references.citation: Nature. 1996 Oct 24;383(6602):722-5
references.pmid: 8878483
references.citation: Mol Biol Cell. 2009 Apr;20(7):1949-59
references.pmid: 19193766
references.citation: Oncogene. 2002 Oct 10;21(46):7011-26
references.pmid: 12370823
references.citation: Scand J Haematol. 1978 Jan;20(1):37-51
references.pmid: 580123
references.citation: Semin Oncol. 2006 Apr;33(2):150-6
references.pmid: 16616061
references.citation: Dev Dyn. 2005 Jan;232(1):1-10
references.pmid: 15580616
references.citation: Blood. 2009 Dec 3;114(24):5081-90
references.pmid: 19828693
references.citation: Immunol Rev. 2008 Feb;221:163-81
references.pmid: 18275481
references.citation: Cancer Biol Ther. 2006 Feb;5(2):228-33
references.pmid: 16481735
references.citation: Am J Physiol Lung Cell Mol Physiol. 2008 Sep;295(3):L431-9
references.pmid: 18599503
references.citation: Cell Growth Differ. 1999 Sep;10(9):629-38
references.pmid: 10511313
references.citation: Genes Dev. 1999 Dec 1;13(23):3125-35
references.pmid: 10601038
references.citation: Immunity. 2007 Jun;26(6):784-97
references.pmid: 17570692
references.citation: Blood. 1993 Jul 1;82(1):262-7
references.pmid: 7686787
references.citation: Ann Hematol. 2002 Jun;81(6):299-303
references.pmid: 12107557
references.citation: Nat Neurosci. 2006 Mar;9(3):322-30
references.pmid: 16491080
references.citation: Cell. 2008 Apr 4;133(1):38-52
references.pmid: 18394988
references.citation: Neurosci Res. 2004 Mar;48(3):285-96
references.pmid: 15154674